Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pds Biotechnology Corp (PDSB)

Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDSB : 1.6500 (-5.71%)
PDS Biotechnology Corporation Announces Key Opinion Leader Event on HPV16-Positive Head and Neck Cancer and Phase 3 Clinical Trial for Versamune® HPV

PDS Biotech announces KOL event to discuss HPV16-positive HNSCC and upcoming clinical trial for Versamune® HPV therapy.Quiver AI SummaryPDS Biotechnology Corporation announced a Key Opinion Leader (KOL)...

PDSB : 1.6500 (-5.71%)
PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET

PDSB : 1.6500 (-5.71%)
PDS Biotechnology: Q3 Earnings Snapshot

PDS Biotechnology: Q3 Earnings Snapshot

PDSB : 1.6500 (-5.71%)
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results

PDSB : 1.6500 (-5.71%)
PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time

PDSB : 1.6500 (-5.71%)
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine

PDSB : 1.6500 (-5.71%)
PDS Biotechnology: Q2 Earnings Snapshot

PDS Biotechnology: Q2 Earnings Snapshot

PDSB : 1.6500 (-5.71%)
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

/CNW/ -- USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

ONCY : 0.8310 (-6.36%)
TCRX : 2.97 (+1.37%)
BMY : 57.33 (+1.83%)
PDSB : 1.6500 (-5.71%)
CCCC : 3.95 (+2.73%)
ONC.TO : 1.19 (-9.16%)
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates

USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale Medicine. As well, there are now alarming reports around...

ONCY : 0.8310 (-6.36%)
ONC.TO : 1.19 (-9.16%)
TCRX : 2.97 (+1.37%)
BMY : 57.33 (+1.83%)
PDSB : 1.6500 (-5.71%)
CCCC : 3.95 (+2.73%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar